COLOMBO, NICOLETTA
COLOMBO, NICOLETTA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
2024 Salani, R; Mccormack, M; Kim, Y; Ghamande, S; Hall, S; Lorusso, D; Barraclough, L; Gilbert, L; Guzman Ramirez, A; Lu, C; Sabatier, R; Colombo, N; Hu, Y; Krishnan, V; Molinero, L; Feng, Y; Kim, N; Castro, M; Lin, Y; Monk, B
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Colombo, N; Biagioli, E; Harano, K; Galli, F; Hudson, E; Antill, Y; Choi, C; Rabaglio, M; Marmé, F; Marth, C; Parma, G; Fariñas-Madrid, L; Nishio, S; Allan, K; Lee, Y; Piovano, E; Pardo, B; Nakagawa, S; Mcqueen, J; Zamagni, C; Manso, L; Takehara, K; Tasca, G; Ferrero, A; Tognon, G; Lissoni, A; Petrella, M; Laudani, M; Rulli, E; Uggeri, S; Barretina Ginesta, M; Zola, P; Casanova, C; Arcangeli, V; Antonuzzo, L; Gadducci, A; Cosio, S; Clamp, A; Persic, M; Mcneish, I; Tookman, L; Redondo Sanchez, A; Baldini, E; Palaia, I; Benedetti Panici, P; Takahashi, N; Lombard, J; Ardizzoia, A; Bologna, A; Herrero Ibáñez, A; Musolino, A; Márquez Vázquez, R; Pietzner, K; Braicu, E; Heinzelmann-Schwarz, V; Powell, M; Yokoyama, Y; Baron-Hay, S; Abeni, C; Martin Lorente, C; Cueva, J; Trillsch, F; Heitz, F; Ataseven, B; Petru, E; Heubner, M; Sadozye, A; Dubey, S; Tazbirkova, A; Tiley, S; Chrystal, K; Kim, S; Fehr, M; Scatchard, K; Anand, A; Taylor, A; Watary, H; Enomoto, T; Yoshihara, K; Selva-Nayagam, S; Karki, B; Harrison, M; Wilkinson, K; Goh, J; Glasgow, A; Chantrill, L; Lee, C; Bertolini, A; Narducci, F; Bellotti, G; Fusco, V; Aebi, S; Del Grande, M; Colombo, I; Tokunaga, H; Shigeta, S; Goss, G; Siow, Z; Steer, C; Lin, H
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2024 Oaknin, A; Gladieff, L; Martínez-García, J; Villacampa, G; Takekuma, M; De Giorgi, U; Lindemann, K; Woelber, L; Colombo, N; Duska, L; Leary, A; Godoy-Ortiz, A; Nishio, S; Angelergues, A; Rubio, M; Fariñas-Madrid, L; Yamaguchi, S; Lorusso, D; Ray-Coquard, I; Manso, L; Joly, F; Alarcón, J; Follana, P; Romero, I; Lebreton, C; Pérez-Fidalgo, J; Yunokawa, M; Dahlstrand, H; D'Hondt, V; Randall, L
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
2024 Colombo, N; Lorusso, D; Monk, B; Slomovitz, B; Hasegawa, K; Nogueira-Rodrigues, A; Zale, M; Okpara, C; Barresi, G; Mckenzie, J; Makker, V
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
2024 Bielo, L; Repetto, M; Crimini, E; Belli, C; Setola, E; Parma, G; Fusco, N; Barberis, M; Rocco, E; Marra, A; Colombo, N; Curigliano, G
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
2024 Boidot, R; Blum, M; Wissler, M; Gottin, C; Ruzicka, J; Chevrier, S; Delhomme, T; Audoux, J; Jeanniard, A; Just, P; Harter, P; Pignata, S; Gonzalez-Martin, A; Marth, C; Maenpaa, J; Colombo, N; Vergote, I; Fujiwara, K; Duforet-Frebourg, N; Bertrand, D; Philippe, N; Ray-Coquard, I; Pujade-Lauraine, E
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma
2024 Gambella, M; Carlomagno, S; Mangerini, R; Colombo, N; Parodi, A; Ghiggi, C; Giannoni, L; Coviello, E; Setti, C; Luchetti, S; Serio, A; Laudisi, A; Passannante, M; Bo, A; Tedone, E; Sivori, S; Angelucci, E; Raiola, A
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
2024 Ledermann, J; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, A; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; Mccluggage, W; Mcneish, I; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, J; Pignata, S; Ramirez, P; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, D; Taskiran, C; van Driel, W; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention
2024 Falanga, A; Lorusso, D; Colombo, N; Cormio, G; Cosmi, B; Scandurra, G; Zanagnolo, V; Marietta, M
Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study
2024 De Vitis, L; Fumagalli, D; Schivardi, G; Capasso, I; Grcevich, L; Multinu, F; Cucinella, G; Occhiali, T; Betella, I; Guillot, B; Pappalettera, G; Shahi, M; Fought, A; Mcgree, M; Reynolds, E; Colombo, N; Zanagnolo, V; Aletti, G; Langstraat, C; Mariani, A; Glaser, G
Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?
2024 Betella, I; De Vitis, L; Calidona, C; Multinu, F; Colombo, N
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: Final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial
2024 Coleman, R; Lorusso, D; Oaknin, A; Cecere, S; Denys, H; Colombo, N; Van Gorp, T; Konner, J; Romeo Marin, M; Harter, P; Murphy, C; Wang, Y; Esteves, B; Method, M; Matulonis, U
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
2024 Schouten, P; Schmidt, S; Becker, K; Thiele, H; Nürnberg, P; Richters, L; Ernst, C; Treilleux, I; Medioni, J; Heitz, F; Pisano, C; Garcia, Y; Petru, E; Hietanen, S; Colombo, N; Vergote, I; Nagao, S; Linn, S; Pujade-Lauraine, E; Ray-Coquard, I; Harter, P; Hahnen, E; Schmutzler, R
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial
2024 Tewari, K; Colombo, N; Monk, B; Dubot, C; Caceres, M; Hasegawa, K; Shapira-Frommer, R; Salman, P; Yanez, E; Gumus, M; de Mendoza, M; Samouelian, V; Castonguay, V; Arkhipov, A; Tekin, C; Li, K; Toker, S; Keefe, S; Lorusso, D
Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins
2024 Caldarelli, M; Rezzi, S; Colombo, N; Pirali, T; Papeo, G
Precision medicine in ovarian cancer: disparities and inequities in access to predictive biomarkers
2024 Barberis, M; Colombo, N; Cerana, N
Reply to P.-H. Luo et al
2024 Monk, B; Colombo, N; Tewari, K; Tekin, C; Keefe, S; Lorusso, D
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
2024 Lorusso, D; Raspagliesi, F; Ronzulli, D; Valabrega, G; Colombo, N; Pisano, C; Cassani, C; Tognon, G; Tamberi, S; Mangili, G; Mammoliti, S; De Giorgi, U; Greco, F; Mosconi, A; Breda, E; Artioli, G; Andreetta, C; Casanova, C; Ceccherini, R; Frassoldati, A; Salutari, V; Giolitto, S; Scambia, G
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)
2024 Durante, S; Cuccia, F; Rigo, M; Caminiti, G; Mastroleo, F; Lazzari, R; Corrao, G; Caruso, G; Vigorito, S; Cattani, F; Ferrera, G; Chiantera, V; Alongi, F; Colombo, N; Jereczek-Fossa, B
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness
2024 Battistini, C; Kenny, H; Zambuto, M; Nieddu, V; Melocchi, V; Decio, A; Lo Riso, P; Villa, C; Gatto, A; Ghioni, M; Porta, F; Testa, G; Giavazzi, R; Colombo, N; Bianchi, F; Lengyel, E; Cavallaro, U